SLICKER PHARMA LIMITED

Company Registration Number:
13949561 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

SLICKER PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

SLICKER PHARMA LIMITED

Company Information

for the Period Ended 31 March 2024




Registered office: 50
Thomas Street
Smethwick
GBR
B66 3QH
Company Registration Number: 13949561 (England and Wales)

SLICKER PHARMA LIMITED

Balance sheet

As at 31 March 2024


2024
£
13 months to
31 Mar 2023
£
Current assets: 6,578 2,366
Creditors: amounts falling due within one year: ( 4,420 ) ( 779 )
Net current assets (liabilities): 2,158 1,587
Total assets less current liabilities: 2,158 1,587
Accruals and deferred income: ( 300 )
Total net assets (liabilities): 2,158 1,287
Capital and reserves: 2,158 1,287

SLICKER PHARMA LIMITED

Balance sheet continued

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 4 November 2024
And Signed On Behalf Of The Board By:

Name: Behzad Saadat
Status: Director

The notes form part of these financial statements

SLICKER PHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Employee Information

    Average number of employees: 2

SLICKER PHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Off balance sheet disclosure

    No